U.S. Psychiatry Clinic Market
Description
U.S. Psychiatry Clinic Market Summary
The U.S. psychiatry clinic market size was estimated at USD 10.96 billion in 2025 and is projected to reach USD 21.60 billion by 2033, growing at a CAGR of 7.79% from 2026 to 2033. This growth is primarily driven by the rising prevalence of mental health disorders such as anxiety, depression, bipolar disorder, and stress-related illnesses, fueled by lifestyle pressures, socio-economic stress, and increasing awareness of mental well-being.
Growing recognition of mental health as an essential component of overall health, along with expanding de-stigmatization, has encouraged more individuals to seek psychiatric care. In addition, advancements in telepsychiatry, digital mental health platforms, and AI-enabled diagnostic support have expanded access to services, particularly in underserved and rural areas. Supportive government initiatives, increasing insurance coverage for behavioral health services, and employer-driven mental health programs further strengthen demand.
U.S. Psychiatry Clinic Market Report Segmentation
This report forecasts revenue growth, country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. psychiatry clinic market report based on service, age group, and region:
The U.S. psychiatry clinic market size was estimated at USD 10.96 billion in 2025 and is projected to reach USD 21.60 billion by 2033, growing at a CAGR of 7.79% from 2026 to 2033. This growth is primarily driven by the rising prevalence of mental health disorders such as anxiety, depression, bipolar disorder, and stress-related illnesses, fueled by lifestyle pressures, socio-economic stress, and increasing awareness of mental well-being.
Growing recognition of mental health as an essential component of overall health, along with expanding de-stigmatization, has encouraged more individuals to seek psychiatric care. In addition, advancements in telepsychiatry, digital mental health platforms, and AI-enabled diagnostic support have expanded access to services, particularly in underserved and rural areas. Supportive government initiatives, increasing insurance coverage for behavioral health services, and employer-driven mental health programs further strengthen demand.
U.S. Psychiatry Clinic Market Report Segmentation
This report forecasts revenue growth, country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. psychiatry clinic market report based on service, age group, and region:
- Service Outlook (Revenue, USD Billion, 2021 - 2033)
- Evaluation & Diagnosis
- Therapy
- Medication Management
- Telepsychiatry
- Ancillary Services
- Age Group Outlook (Revenue, USD Billion, 2021 - 2033)
- Adult
- Geriatric
- Pediatric
- Region Outlook (Revenue, USD Billion, 2021 - 2033)
- Southeast
- Midwest
- West
- Northeast
- Southwest
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Service
- 1.2.2. Component
- 1.2.3. Provider
- 1.2.4. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing demand for quick rehydration and recovery solutions
- 3.2.1.2. Increasing adoption of wellness and preventive healthcare trends
- 3.2.1.3. Rising popularity of IV nutrient therapy for beauty, skin rejuvenation, and anti-aging benefits
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Risk of side effects, including infections, vein inflammation, or allergic reactions
- 3.2.2.2. High cost of treatments compared to oral supplements and conventional care
- 3.2.2.3. Limited insurance coverage, making therapies less accessible to many patients
- 3.2.3. Industry Opportunity Analysis
- 3.2.4. Industry Challenge Analysis
- 3.2.5. Pricing Analysis
- 3.2.6. Emerging Trends
- 3.3. Business Environment Analysis
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal Landscape
- Chapter 4. Intravenous (IV) Hydration Therapy Market: Service Estimates & Trend Analysis
- 4.1. Service Segment Dashboard
- 4.2. Service Market Share Movement Analysis, 2025 & 2033
- 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2021 to 2033 (USD Million)
- 4.4. Immune Boosters
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Energy Boosters
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Hydration
- 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Beauty/ Aesthetics
- 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.8. Detoxification
- 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.9. Longevity/ Antiaging
- 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.10. Performance/ Athletics
- 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.11. Migraine & Pain Relief
- 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.12. Stress/Sleep/Mood Support
- 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.13. Flu/Stomach
- 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.14. Others
- 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Intravenous (IV) Hydration Therapy Market: Component Estimates & Trend Analysis
- 5.1. Component Segment Dashboard
- 5.2. Component Market Share Movement Analysis, 2025 & 2033
- 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
- 5.4. Medicated
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Non-Medicated
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Intravenous (IV) Hydration Therapy Market: Provider Estimates & Trend Analysis
- 6.1. Provider Dashboard
- 6.2. Provider Market Share Movement Analysis, 2025& 2033
- 6.3. Market Size & Forecasts and Trend Analysis, by Provider, 2021 to 2033 (USD Million)
- 6.4. Mobile Providers
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Physical Providers
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Intravenous (IV) Hydration Therapy Market: End Use Estimates & Trend Analysis
- 7.1. End Use Segment Dashboard
- 7.2. End Use Market Share Movement Analysis, 2025 & 2033
- 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 7.4. Healthcare Providers
- 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Hospitals & Clinics
- 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Wellness Centers & Spas
- 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Home Healthcare
- 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Others
- 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Intravenous (IV) Hydration Therapy Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Dashboard
- 8.2. Regional Market: Key Takeaways
- 8.3. North America
- 8.3.1. North America Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key country dynamic
- 8.3.2.2. Regulatory framework
- 8.3.2.3. Competitive insights
- 8.3.2.4. U.S. Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key country dynamic
- 8.3.3.2. Regulatory framework
- 8.3.3.3. Competitive insights
- 8.3.3.4. Canada Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key country dynamic
- 8.3.4.2. Regulatory framework
- 8.3.4.3. Competitive insights
- 8.3.4.4. Mexico Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4. Europe
- 8.4.1. Europe Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.2. Germany
- 8.4.2.1. Key country dynamic
- 8.4.2.2. Regulatory framework
- 8.4.2.3. Competitive insights
- 8.4.2.4. Germany Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.3. UK
- 8.4.3.1. Key country dynamic
- 8.4.3.2. Regulatory framework
- 8.4.3.3. Competitive insights
- 8.4.3.4. UK Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key country dynamic
- 8.4.4.2. Regulatory framework
- 8.4.4.3. Competitive insights
- 8.4.4.4. France Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key country dynamic
- 8.4.5.2. Regulatory framework
- 8.4.5.3. Competitive insights
- 8.4.5.4. Italy Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key country dynamic
- 8.4.6.2. Regulatory framework
- 8.4.6.3. Competitive insights
- 8.4.6.4. Spain Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Key country dynamic
- 8.4.7.2. Regulatory framework
- 8.4.7.3. Competitive insights
- 8.4.7.4. Denmark Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Key country dynamic
- 8.4.8.2. Regulatory framework
- 8.4.8.3. Competitive insights
- 8.4.8.4. Sweden Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key country dynamic
- 8.4.9.2. Regulatory framework
- 8.4.9.3. Competitive insights
- 8.4.9.4. Norway Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key country dynamic
- 8.5.2.2. Regulatory framework
- 8.5.2.3. Competitive insights
- 8.5.2.4. Japan Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key country dynamic
- 8.5.3.2. Regulatory framework
- 8.5.3.3. Competitive insights
- 8.5.3.4. China Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key country dynamic
- 8.5.4.2. Regulatory framework
- 8.5.4.3. Competitive insights
- 8.5.4.4. India Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key country dynamic
- 8.5.5.2. Regulatory framework
- 8.5.5.3. Competitive insights
- 8.5.5.4. South Korea Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Key country dynamic
- 8.5.6.2. Regulatory framework
- 8.5.6.3. Competitive insights
- 8.5.6.4. Australia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Key country dynamic
- 8.5.7.2. Regulatory framework
- 8.5.7.3. Competitive insights
- 8.5.7.4. Thailand Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America Intravenous (IV) Hydration Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key country dynamic
- 8.6.2.2. Regulatory framework
- 8.6.2.3. Competitive insights
- 8.6.2.4. Brazil Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key country dynamic
- 8.6.3.2. Regulatory framework
- 8.6.3.3. Competitive insights
- 8.6.3.4. Argentina Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7. MEA
- 8.7.1. MEA Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Key country dynamic
- 8.7.2.2. Regulatory framework
- 8.7.2.3. Competitive insights
- 8.7.2.4. South Africa Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Key country dynamic
- 8.7.3.2. Regulatory framework
- 8.7.3.3. Competitive insights
- 8.7.3.4. Saudi Arabia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key country dynamic
- 8.7.4.2. Regulatory framework
- 8.7.4.3. Competitive insights
- 8.7.4.4. UAE Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key country dynamic
- 8.7.5.2. Regulatory framework
- 8.7.5.3. Competitive insights
- 8.7.5.4. Kuwait Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Participant Overview
- 9.2. Company Market Position Analysis
- 9.3. Company Categorization
- 9.4. Strategy Mapping
- 9.5. Company Profiles/Listing
- 9.5.1. Baxter International Inc.
- 9.5.1.1. Overview
- 9.5.1.2. Financial performance
- 9.5.1.3. Product benchmarking
- 9.5.1.4. Strategic initiatives
- 9.5.2. B. Braun Melsungen AG
- 9.5.2.1. Overview
- 9.5.2.2. Financial performance
- 9.5.2.3. Product benchmarking
- 9.5.2.4. Strategic initiatives
- 9.5.3. Otsuka Pharmaceutical Co., Ltd.
- 9.5.3.1. Overview
- 9.5.3.2. Financial performance
- 9.5.3.3. Product benchmarking
- 9.5.3.4. Strategic initiatives
- 9.5.4. Grifols, S.A.
- 9.5.4.1. Overview
- 9.5.4.2. Financial performance
- 9.5.4.3. Product benchmarking
- 9.5.4.4. Strategic initiatives
- 9.5.5. Vifor Pharma Management Ltd.
- 9.5.5.1. Overview
- 9.5.5.2. Financial performance
- 9.5.5.3. Product benchmarking
- 9.5.5.4. Strategic initiatives
- 9.5.6. JW Life Science Corporation
- 9.5.6.1. Overview
- 9.5.6.2. Financial performance
- 9.5.6.3. Product benchmarking
- 9.5.6.4. Strategic initiatives
- 9.5.7. Amanta Healthcare
- 9.5.7.1. Overview
- 9.5.7.2. Financial performance
- 9.5.7.3. Product benchmarking
- 9.5.7.4. Strategic initiatives
- 9.5.8. NexGen Health
- 9.5.8.1. Overview
- 9.5.8.2. Financial performance
- 9.5.8.3. Product benchmarking
- 9.5.8.4. Strategic initiatives
- 9.5.9. Core IV Therapy, LLC
- 9.5.9.1. Overview
- 9.5.9.2. Financial performance
- 9.5.9.3. Product benchmarking
- 9.5.9.4. Strategic initiatives
- 9.5.10. Cryojuvenate UK Ltd.
- 9.5.10.1. Overview
- 9.5.10.2. Financial performance
- 9.5.10.3. Product benchmarking
- 9.5.10.4. Strategic initiatives
- 9.5.11. Drip Hydration
- 9.5.11.1. Overview
- 9.5.11.2. Financial performance
- 9.5.11.3. Product benchmarking
- 9.5.11.4. Strategic initiatives
- 9.5.12. REVIV
- 9.5.12.1. Overview
- 9.5.12.2. Financial performance
- 9.5.12.3. Product benchmarking
- 9.5.12.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



